142 related articles for article (PubMed ID: 19838105)
1. Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment.
Chua TC; Saxena A; Schellekens JF; Liauw W; Yan TD; Fransi S; Zhao J; Morris DL
Ann Surg; 2010 Jan; 251(1):101-6. PubMed ID: 19838105
[TBL] [Abstract][Full Text] [Related]
2. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy--a journey to becoming a Nationally Funded Peritonectomy Center.
Yan TD; Links M; Fransi S; Jacques T; Black D; Saunders V; Morris DL
Ann Surg Oncol; 2007 Aug; 14(8):2270-80. PubMed ID: 17464543
[TBL] [Abstract][Full Text] [Related]
3. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive cases.
Yan TD; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
Ann Surg Oncol; 2007 Feb; 14(2):515-25. PubMed ID: 17031722
[TBL] [Abstract][Full Text] [Related]
4. Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures.
Saxena A; Yan TD; Morris DL
Eur J Surg Oncol; 2010 Mar; 36(3):309-14. PubMed ID: 19615849
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
6. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
Sugarbaker PH; Alderman R; Edwards G; Marquardt CE; Gushchin V; Esquivel J; Chang D
Ann Surg Oncol; 2006 May; 13(5):635-44. PubMed ID: 16523363
[TBL] [Abstract][Full Text] [Related]
7. Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database.
Yan TD; Zappa L; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
J Surg Oncol; 2007 Aug; 96(2):102-12. PubMed ID: 17221852
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution.
Chua TC; Yan TD; Smigielski ME; Zhu KJ; Ng KM; Zhao J; Morris DL
Ann Surg Oncol; 2009 Jul; 16(7):1903-11. PubMed ID: 19387742
[TBL] [Abstract][Full Text] [Related]
9. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy.
Jacquet P; Stephens AD; Averbach AM; Chang D; Ettinghausen SE; Dalton RR; Steves MA; Sugarbaker PH
Cancer; 1996 Jun; 77(12):2622-9. PubMed ID: 8640714
[TBL] [Abstract][Full Text] [Related]
10. Postoperative pancreatic fistula after cytoreductive surgery and perioperative intraperitoneal chemotherapy: incidence, risk factors, management, and clinical sequelae.
Saxena A; Chua TC; Yan TD; Morris DL
Ann Surg Oncol; 2010 May; 17(5):1302-10. PubMed ID: 20087784
[TBL] [Abstract][Full Text] [Related]
11. Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion.
Ahmad SA; Kim J; Sussman JJ; Soldano DA; Pennington LJ; James LE; Lowy AM
Ann Surg Oncol; 2004 Apr; 11(4):387-92. PubMed ID: 15070598
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis.
Klaver YL; Chua TC; de Hingh IH; Morris DL
J Surg Oncol; 2012 Feb; 105(2):113-8. PubMed ID: 21780124
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL
Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection.
Chua TC; Yan TD; Zhao J; Morris DL
Eur J Surg Oncol; 2009 Dec; 35(12):1299-305. PubMed ID: 19632081
[TBL] [Abstract][Full Text] [Related]
16. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.
Kecmanovic DM; Pavlov MJ; Ceranic MS; Sepetkovski AV; Kovacevic PA; Stamenkovic AB
Eur J Surg Oncol; 2005 Mar; 31(2):147-52. PubMed ID: 15698730
[TBL] [Abstract][Full Text] [Related]
17. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy.
Hansson J; Graf W; Påhlman L; Nygren P; Mahteme H
Eur J Surg Oncol; 2009 Feb; 35(2):202-8. PubMed ID: 18514475
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach.
Sugarbaker PH
Expert Opin Pharmacother; 2009 Aug; 10(12):1965-77. PubMed ID: 19563273
[TBL] [Abstract][Full Text] [Related]
20. Management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy.
Gómez Portilla A; Barrios P; Rufian S; Camps B; Bretcha P; Gonzalez Bayon L; Torres Melero J; García Polavieja M; Gonzalez Moreno S
Eur J Surg Oncol; 2006 Aug; 32(6):628-31. PubMed ID: 16682169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]